Abstract
A serious adverse clinical effect of glucocorticoid steroid treatment is secondary osteoporosis, enhancing fracture risk in bone. This rapid increase in bone fracture risk is largely independent of bone loss (quantity), and must therefore arise from degradation of the quality of the bone matrix at the micro- and nanoscale. However, we lack an understanding of both the specific alterations in bone quality n steroid-induced osteoporosis as well as the mechanistic effects of these changes. Here we demonstrate alterations in the nanostructural parameters of the mineralized fibrillar collagen matrix, which affect bone quality, and develop a model linking these to increased fracture risk in glucocorticoid induced osteoporosis. Using a mouse model with an N-ethyl-N-nitrosourea (ENU)-induced corticotrophin releasing hormone promoter mutation (Crh− 120/+) that developed hypercorticosteronaemia and osteoporosis, we utilized in situ mechanical testing with small angle X-ray diffraction, synchrotron micro-computed tomography and quantitative backscattered electron imaging to link altered nano- and microscale deformation mechanisms in the bone matrix to abnormal macroscopic mechanics. We measure the deformation of the mineralized collagen fibrils, and the nano-mechanical parameters including effective fibril modulus and fibril to tissue strain ratio. A significant reduction (51%) of fibril modulus was found in Crh− 120/+ mice. We also find a much larger fibril strain/tissue strain ratio in Crh− 120/+ mice (~ 1.5) compared to the wild-type mice (~ 0.5), indicative of a lowered mechanical competence at the nanoscale. Synchrotron microCT show a disruption of intracortical architecture, possibly linked to osteocytic osteolysis. These findings provide a clear quantitative demonstration of how bone quality changes increase macroscopic fragility in secondary osteoporosis.
Keywords: Glucocorticoid induced osteoporosis, In situ micro mechanical testing, Synchrotron small angle X-ray scattering, Nanoscale deformation mechanisms, Multiscale imaging
Graphical abstract
Highlights
-
•
In steroid induced osteoporosis, the mineralized collagen fibrils exhibit lower stiffness and a more random orientation distribution.
-
•
Load induced reorientation at the fibrillar level is reduced in steroid induced osteoporosis compared to wild type.
-
•
Reduced and more heterogeneous mineralization at the microscale was accompanied by significant increases in porosity.
1. Introduction
Anti-inflammatory glucocorticoid treatments are mostly prescribed to an elderly population suffering from diverse disorders such as asthma, rheumatoid arthritis, immune diseases and following organ transplants [1]. However, glucocorticoid induced osteoporosis (GIOP), a form of secondary osteoporosis, is a clinically serious long term side effect of glucocorticoid treatment, resulting in loss in cancellous bone followed by cortical bone [2] and affecting 0.5% of the general population [3]. Osteoporotic fractures associated with glucocorticoid use occur in up to 30–50% of patients on chronic glucocorticoid therapy [4]. Further, GIOP is the most notable clinical skeletal disorder where the established paradigm of using only bone quantity to predict fractures is clearly insufficient to explain increased fracture risk, as bone mineral density (BMD) measurements show no significant association with fractures. GIOP patients have greater risk of fracture at higher BMDs when compared to postmenopausal osteoporotic women [1], [5]. It has been shown that glucocorticoid therapy affects both the amount of bone (bone quantity) as well as the micro-architecture and material level properties (local elastic modulus around osteocytes [6], crystal orientation and the degree of mineralization [6], [7] of the matrix) (bone quality) due to the down-regulation of bone-forming osteoblasts with concurrent alteration in the bone remodeling cycle [8]. Up to 40% reduction of both the mineral to matrix ratio and the elastic modulus (down to 14 GPa) was observed around osteocyte lacunae in [6], along with 18% reductions in trabecular bone volume, 12% lower trabecular connectivity and 7% lower trabecular number as measured with microcomputed tomography. However, the mechanisms by which these micro- and nanoscale changes in bone material quality lead to increased fracture risk in GIOP are currently unknown.
Deformation mechanisms at multiple structural levels between the nano- and the microscale – from the largest (osteons ~ 200 μm in diameter) down to the smallest (tropocollagen molecules and carbonated apatite crystallites) – lead to load-bearing bones achieving both a high stiffness and high work of fracture [9], [10], [11], [12]. Bone quality changes occur initially at the smaller length scales, dictated by rates of formation of new basic multicellular units by osteoblasts, at level of lamellae (~ 5 μm) and mineralized fibrils (~ 200 nm). Alterations in the bone extracellular matrix induced by glucocorticoid therapy are downstream effects of altered cellular activity of bone cells in the pathological condition and may be involved in the reductions of the global mechanical competence of bone. However, a gap exists both in our knowledge of the structural changes in GIOP [6], [7], and more significantly in the relation between such structural changes at the bone material level and the increased macroscopic fragility in GIOP. Therefore, there is a clear need to apply high-resolution imaging techniques to close the gap between onset of fracture relevant changes and diagnosis. We hypothesize that enhanced fracture risk in GIOP is associated with nanomechanical alterations at the fibrillar level, which link into larger scale deformation mechanisms. Here, to test this hypothesis, we combine multi-scale imaging techniques and mechanical testing on an animal model of GIOP.
For the animal model for GIOP, a recently published mouse model of endogenous hypercorticosteronaemia (Cushing's syndrome) was used [13], as the fracture risk associated with endogenous and exogenous GIOP have been shown to be similar [3]. The mouse model was generated via an N-ethyl-N-nitrosourea (ENU) induced mutation of the corticotrophin releasing hormone (Crh) promoter. The mutation, which involved a T-to-C transition at − 120 bp within the Crh promoter, resulted in increased transcription activity, and in vivo assessment of Crh− 120/+ mice revealed them to have obesity, hypercorticosteronaemia, hyperglycaemia, and low bone mineral density (BMD) when compared to wild-type (WT) mice. Crh− 120/+ mice, when compared to WT mice, showed reduction in mineralizing surface area, mineral apposition rate, bone formation rate and osteoblast number; this was also accompanied by an increase in adipocytes in the bone marrow. These phenotypic changes validate the used of the Crh− 120/+ mice as a model for Cushing's syndrome and GIOP [13].
In this study, the alterations in fibrillar-level deformability, mineralization and cortical micro-architecture in GIOP can thus be quantified and linked to macroscale mechanical properties using in situ X-ray nanomechanical imaging [14], [15] synchrotron micro-computed tomography and scanning electron microscopic investigations respectively.
2. Material and methods
2.1. Study design and cohort
Crh− 120/+ mice were identified in a dominant ENU mutagenesis screen at the MRC MGU Harwell [13]. Female Crh− 120/+ mice on a C57BL/6 genetic background (third generation) were used in all experiments; littermate WT mice were used as controls. Animals were 26 weeks of age at the time of sacrifice. Animals were anaesthetised before cervical dislocation; internal organs were removed from the body cavity and the whole body skeleton stored at − 20 °C until used.
2.2. Backscattered scanning electron (BSE) imaging
Quantitative BSE (qBSE) imaging was performed on transverse cross section at the mid-diaphysis to determine the microscale degree of mineralization. Mice femora (Crh− 120/+ = 5 and WT = 5) were sectioned into halves using a low speed diamond saw before dehydrating in ethanol and embedding in poly-methyl-methacrylate (PMMA) [16], [17]. Digital BSE imaging was performed with an Inspect-F, FEI scanning electron microscope equipped with an annular solid state BSE detector. The electron beam was adjusted to 20 kV accelerating voltage and 160 μA sample current was used to perform the analytical imaging. The working distance in the SEM was adjusted to 15 mm. The pixel resolution of the Digital BSE images from the midshaft transverse cross section was 0.3125 μm 1024 × 943 pixels) with gray level resolution of 256. These gray levels values were converted into calcium weight% values using carbon and aluminum (Micro-Analysis Consultants Ltd., Cambridgeshire UK) as gray level references. In Crh− 120/+ mice bone, two distinct regions (cavity region in the endosteal cortex and periosteal cortex) were observed. Three (WT) to six (Crh− 120/+: 3 from endosteal cortex and 3 from periosteal cortex) regions of interest (50 × 50 μm) from each BSE image (Crh− 120/+ = 5 and WT = 5) of the anterior transverse cortex were used to produce the grey level histograms. Using BMDD histograms, the mean calcium weight percentage Camean and full width at half maximum (FWHM) [18] were calculated.
2.3. Synchrotron X-ray computed tomography
Synchrotron radiation microCT was performed at the imaging beam line I13-2 at Diamond Light Source (Harwell, UK) to visualize the vascular canal network. Three tibiae specimens from three WT mice and three tibiae from three Crh− 120/+ mice were oriented with their longitudinal axis parallel to the rotation axis during scanning. The effective voxel size was 1.6 μm3, providing a spatial resolution of 3.2 μm and field of view of 4.2 × 3.5 μm. Tomographic scans were obtained using photon energy of 18 keV and exposure time was 0.1 s. For each 3D data set, a total of 3600 projections were acquired over a range of 180°. The Diamond Light Source in-house algorithm was used to reconstruct tomographic data and 3D volumetric visualization of tibiae mid diaphysis was created by segmentation tools in Avizo 3D software (Burlington, MA, USA). Image volumes at the mid diaphysis of 1.35 × 1.34 × 1.00 mm3 were used for further morphometric analysis. Using Aviso intracortical cortical lacunae and canals were segmented from dense cortical tissue with simple thresholding due to their densities being significantly different, and this also provided volume measurements of the bone. STL meshes were created for segmented volumes (lacunae and canals) and imported into Blender software (Blender Foundation, Amsterdam, Netherlands) where it was separated by loose parts (unconnected mesh components) to give a total count of lacunae, canals and artefacts. The artifacts largely occurred outside the bone so could be selected, isolated and counted in Blender (using the same method as above). The mesh was then imported into Meshlab (http://meshlab.sourceforge.net/) where components less than 1% of the total mesh size were removed with the “remove isolated components (with respect to diameter) algorithm” leaving mainly the canals which could then be manually counted. Both the artefact and canals counts were then subtracted from the total count to give the lacunae number. We derived morphometric measures for female Crh− 120/+ and wild-type littermates, including lacunae number density (number of lacunae/cortical tissue volume) and canal number density (number of lacunae/cortical tissue volume).
2.4. Sample preparation for in situ tensile testing with SAXD
Mouse femora (Crh− 120/+ = 6 and WT = 4) from female Crh− 120/+ and wild-type littermates were dissected, skinned and muscle tissue removed. Then the bones were systematically prepared [17] for in-situ tensile testing (see Supplementary information for full detail). Bone strips only from anterior sections of the femora were used in this experiment such that long axis of specimens are parallel to the femur. The average length, width and thickness of the gauge regions were 5.0 mm, 1.0 mm and 0.2 mm, respectively.
2.5. In-situ tensile loading with small angle X-ray scattering
Samples were loaded at a constant velocity of 1 μm/s (strain rate = 0.02%/s) in a custom-made micromechanical testing machine [17] in the path of a microfocus synchrotron X-ray beam at beamline I22, Diamond Light Source (Harwell, UK). A schematic of the experimental setup is shown in Fig. S1 (Supplementary data). Samples were maintained in physiological saline in a fluid chamber and strained at 10− 4 s− 1, with SAXD spectra taken every 0.05% tissue strain up to failure (~ 0.5–1.0%). X-ray wavelength λ was 0.8857 Å and beam cross section 10 μm × 12 μm. Sample to detector distance was 1.034 m, measured with a calibration standard (type I collagen). During the experiment, exposure time for each SAXD spectra was kept to approximately 1 s, limiting the total X-ray radiation dosage to 29.4 kGy to minimise the influence of the X-ray radiation on the bone mechanical properties [19]. The collagen fibril strain εf was measured from change of the centre position q0 of the third order reflection peak, as described previously [14], [15], [20]. 2D SAXD patterns were reduced to one dimensional profiles by radial integration over a 20° sector oriented parallel to the tensile loading axis (Fig. S1). Subsequently, the third-order meridional fibrillar reflections were fitted to Gaussians with a linear background term obtain peak position q0. Axial fibrillar periodicity D = 6π / q0, and fibril strain equals the percentage increases in D relative to the unstressed state. Tissue strain was measured by non-contact video extensometry of displacement of horizontal optical markers (Fig. S1C inset i) on the bone mid diaphysis. We consider only the elastic regime of bone deformation in this paper, and hence only data collected from the linear region was used for further analysis. The elastic region for each sample was identified using the baseline of > 10% reduction the slope of the stress strain curve, shown in Fig. S2 in supplementary information.
2.6. Degree of fibrillar orientation
To determine the degree of orientation of the collagen fibrils with respect to the loading axis, the full width at half maximum of the meridional 3rd order reflection Ic(χ) was estimated from unstrained samples. To eliminate mineral scattering background in SAXD, the total azimuthal intensity I(χ;q0) at q = q0 and the azimuthal distribution of mineral-scattering Im;c(χ;q = ± 5)were calculated. I(χ; q0) was calculated by radially averaging the SAXD intensity in a narrow band around q0. Im;c(χ) was similarly calculated by averaging I(χ) at wave-vectors lower ql and higher qh (Fig. S1D a and c) than q0 (Fig. S1D b). Ic(χ) is the difference between I(χ;q0) and Im;c(χ;q = ± 5). The angular intensity of the 3rd order fibril reflection Ic(χ) is plotted in Fig. S1F. The intensity was fitted to a Gaussian function I(χ) = I0 exp(−((χ − χ0) / Δχ0)2 / 2), where χ0 is the centre of the intensity distribution and Δχ0 proportional to the width (FWHM). The average rates of collagen fibrillar reorientation were determined for WT = 4 and Crh− 120/+ = 6 by calculating the slopes of FWHM vs. tissue strain curves.
2.7. Statistical analysis
To compare nanomechanical and synchrotron X-ray micro-computed tomography results between WT and Crh− 120/+ mice, Student t-tests were performed. One way ANOVA test with post-hoc Tukey HSD test was performed on mean calcium weight percentage Camean and full width at half maximum (FWHM) data to assess statistical significance between periosteal and endosteal regions of Crh-120/+ mice and their WT littermates. Excel 2007 (Microsoft Office 2007) was used for the Student t-test, ANOVA and post-hoc Tukey HSD test.
3. Results
3.1. BSE Imaging and quantitative analysis
Backscattered scanning electron microscopy (BSE) was performed on femoral transverse cross sections to examine possible mineralization defects in Crh− 120/+ mice. Cortical microstructure of the Crh− 120/+ mice (Fig. 1B) femora was markedly different to the WT mice (Fig. 1A) cortical structure. BSE images of femoral transverse cross-sections of WT mice showed a uniform cortical thickness, whereas in the Crh− 120/+ mice, the posterior cortex was substantially thinner compared to the anterior cortex. The anterior, lateral and medial cross sections of Crh− 120/+ femora had a very large fraction of cavities. In contrast, WT femoral bone was uniformly dense around the full cortex. High magnification BSE images (Fig. 1A bottom) of the WT cortex show uniformly distributed lacunae. However, in Crh− 120/+ mice osteocytic area is low compared to WT mice. Strikingly, Crh− 120/+ mice cortices had numerous localized cement lines surrounding low mineralized tissue (Fig. 1B, lower image, (i)) near cavities, which were absent in WT cortices. These structures were ~ 50 × 50 μm in area, surrounded a significant number of osteocytes and localized to the endosteal cortex.
Bone mineralization density distribution (BMDDs) histograms (Fig. 2A) were plotted for Crh− 120/+ and WT femoral transverse cross-sections. Since we observed very distinct intra-tissue (regions surrounded by the localized cement lines) variation of mineralization on the Crh− 120/+ mice femora as reported above, both regions (Fig. 1Bi and ii) were used separately for quantitative BSE analysis. Crh− 120/+ mice showed a lowered average mineral content compared to WT (Fig. 1B). Mean calcium weight percentage (Camean) was lowest at regions (area surrounded by the cement lines) near the cavities in Crh− 120/+ mice (27.06 ± 1.18 S.D. (Fig. 2B), and significantly greater in the cortical periosteum (p < 0.01) at the regions away from cavities (28.44 ± 0.84 S.D.) (Fig. 1Bii). WT mice (30.32% ± 1.09 S.D.) had significantly higher (p < 0.01 for both WT vs. regions near and away from cavities in Crh− 120/+ mice) Camean compared to Crh− 120/+ mice. The homogeneity of tissue-level mineralization (FWHM) was highest at regions around cavities (6.43 ± 1.30 S.D.) in Crh− 120/+ mice (Fig. 2C), and substantially lower in regions near the periosteal surfaces (4.63 ± 0.73 S.D.) away from the cavities. In contrast to Crh− 120/+ mice bones, WT mice had significantly lower (p < 0.01) FWHM (3.80 ± 1.02 S.D.).
3.2. Synchrotron X-ray micro-computed tomography
In order to gain better understanding of 3D distribution of cavities and micro structure of cortical bone, synchrotron X-ray micro tomography imaging was carried out. Results presented in Fig. 3C and D show most of these cavities (red; color online) are localized into the anterior cortico-endosteal bone along the tibiae shaft. These localized cavities are not present in WT mice. 3D reconstructions of vascular canal network and lacunae (segmented with yellow color; color online) presented in Fig. 3B show that WT and Crh− 120/+ bones have individual canals directly connected to the medullary cavity. However, WT bone exhibited very condensed network of canals and osteocyte lacunae homogenously distributed across the cortical bone. In contrast, in Crh− 120/+ mice most of the canal network and lacunae space have been replaced by cavities (Fig. 3B and C). Morphometric evaluation on vascular canals and osteocyte lacunae are shown in Fig. 4A and B respectively. These results indicated a significant reduction in canal density (p < 0.05) and lacunae density (p < 0.001) in Crh− 120/+ mice bones. Average volume fractions for porous sections (red segmented sections in Fig. 3) and residual regions (purple segmented sections in Fig. 3)) are 0.025 and 0.0083 respectively. In contrast, in WT mice no such structures were observed.
Furthermore, Crh− 120/+ mice bones exhibits some unmineralized tissue (Fig. 3A and segmented with purple color in Fig. 3B, C and D; color online) within the medullary cavity attached to the cortico-endosteal bone. This tissue has lower gray value (lower mineral content) compared to the cortical bone of Crh− 120/+ mice. The increased cavity structure (red voids; color online) in Crh− 120/+ mice bone is present across the entire length of the bone shaft, as evidenced from synchrotron X-ray microCT measurements across the entire mid-diaphysis (Supplementary Video S1, Video S2).
3.3. In situ tensile loading with synchrotron SAXD
Tissue level and fibrillar and mechanics of cortical bone from femoral mid-diaphyses of 26 week old WT (n = 4) and Crh− 120/+ (n = 6) mice were measured using in situ micro mechanical tensile testing combined with microfocus SAXD. Porosity-corrected stress versus tissue strain was plotted (Fig. 5A) as a function of genotype. Tissue level elastic moduli are significantly (p < 0.05) lower in Crh− 120/+ mice compared to WT mice (Fig. 5A inset). Average yield stress (Fig. 5B) of the WT mice (28.2 MPa ± 7.1 S.D.) is significantly larger compared to Crh− 120/+ mice (16.2 MPa ± 7.3 S.D.). Tissue yield strain of Crh− 120/+ mice was not significantly different (p > 0.05) from WT mice (Fig. 5C).
Considering the fibrillar-level deformation, the gradient of stress versus fibril strain (Fig. 6A) in the elastic regime is denoted as the effective fibril modulus (Ef = dσ / dεf), as per our previous definition [17]. Average fibril modulus (Fig. 6B) shows a significant (p < 0.05) reduction of ~ 79% in Crh− 120/+ bone relative to WT. To calculate the fraction of tissue strain taken up at fibrillar level [15], fibril strain was plotted against macroscopic strain (Fig. 6C). Gradients of fibril strain (εF) versus tissue strain (εT) are clearly different (Fig. 6D), with the dεF/dεT much higher in Crh− 120/+ mice compared to WT (1.18 ± 0.43) compared to 0.57 ± 0.2 S.D.) Maximal fibril strain for Crh− 120/+ specimens (0.63% ± 0.22 S.D.) was significantly higher (p < 0.05) compared to WT mice (0.3% ± 0.25 S.D.) (Data not shown).
The degree of fibrillar orientation (FWHM) between WT and Crh− 120/+ mice at unloaded state was significantly (p < 0.01) higher compared to WT, indicating a lesser degree of fibrillar alignment relative to the tensile axis (Fig. 6E). The load-induced fibrillar reorientation, the percentage change in fibrillar orientation (from the unloaded state for each sample) for WT and Crh− 120/+ mice shows the resultant change, indicating that the fibrillar orientation reduces for all samples (Fig. 6F), but is much less pronounced than Crh− 120/+ mice relative to WT mice. Rate of fibrillar reorientation with fibrillar deformation in Crh− 120/+ mice is significantly lower (p < 0.05) compared to WT mice.
4. Discussion
Here, we have applied a combination of nano- and microscale structural and mechanical probes to quantify the mechanisms by which bone material quality changes in a mouse model of GIOP [13] leads to increased macroscopic fragility. Glucocorticoid-induced osteoporosis [21], [22] is an especially appropriate osteoporosis model to clarify the mechanistic role of bone quality, as it is well-established (e.g. in postmenopausal women [23]) that the steroid-increased increase of fracture risk appears uncorrelated to changes in bone quantity. Nonetheless, while cellular changes in bone metabolism have been identified in GIOP [2], [6], less is known about the alterations in bone material [24], [25], and very little about the altered deformation mechanisms of the bone material in GIOP. We used X-ray nanomechanical imaging techniques combined with micro-structural probes of mineral content and 3D microarchitecture to provide a quantitative link between structure at the nano- and microscale and the mechanical quality deterioration in a mouse model for Cushing's syndrome, with relevance for GIOP.
While the mouse model used in this study exhibits endogenous steroid production characteristic of Cushing's syndrome [13], which is in contrast to the usual etiology of GIOP where steroids are administered exogenously as part of anti-inflammatory medication [1], there are sufficient similarities to make it a worthwhile comparison. The Crh− 120/+ mice in this study have been previously shown [13] to exhibit osteoporosis, specifically showing reduced bone formation, number of osteoblasts, mineral apposition rate, and fraction of the endosteal surface of cortical bone which was covered by osteoblasts. Further, an increased adipocyte concentration in Crh− 120/+ mice [18] suggest that bone marrow stromal cells preferentially differentiate to adipocytes rather than osteoblasts, as seen in GIOP [11], [26] In addition, atomic force microscopy and other imaging methods have shown [6], [24], [27] that GIOP cortical murine bone exhibits “haloes” of lesser mineralized tissue around osteocyte lacunae. Similar microstructural alterations are observed in the current mouse model as well as significantly altered 3D microstructural architecture, which gives confidence that the alterations in bone matrix mechanics and structure visible here are relevant to the case of GIOP. As discussed earlier [13], the current model can hence be considered a complement to existing models of exogenously induced GIOP [2], [28], [29] with special application to understanding the longer-term effects of GIOP on bone structure and quality, in line with the continuous production of steroids over the lifetime of the animal.
The main findings of our study can be summarized as follows:
-
•
Nanoscale mechanical alterations: We observed a reduced fibril modulus, increased fibrillar extensibility, increased randomness of fibril texture and reduced rate of fibrillar reorientation in the cortical bone of Crh− 120/+ mice subjected to tensile loading, compared to WT controls
-
•
Microscale material and structural alterations: A reduced average mineral content and increased heterogeneity of mineralization were accompanied by significant increases in porosity and alterations in 3D microarchitecture, presence of lower mineralized tissue around these pores and disrupted endosteal structure in the cortices of Crh− 120/+ mice compared to WT controls.
-
•
Macromechanical changes: The tissue-level stiffness reduced, the maximum tissue strain increased and the breaking stress reduced also reduced in the bones of Crh− 120/+ mice compared to WT controls.
In the following, we will discuss these findings, and their relation to existing knowledge about the alteration of bone structure in GIOP as well as in related disorders like Cushing's syndrome in more detail.
At the microstructural level, the microCT images indicate substantial, interconnected pores inside the cortex of bones, which is accompanied by the reduction in mineralization of the remaining matrix. The open question is whether this difference is the product of disrupted endosteal structure, or due to the presence of blood vessels inside these cavities, leading to Haversian-type remodelling with secondary tissue formation. From prior histochemical studies of this model [13], it is found that due to a combination of reduced osteoblast coverage on the cortico-endosteal surface, a lower mineralizing rate and lower overall number of osteoblasts, the endosteal surface develops with a ruffled, porous surface characteristic of cancellous bone, which are the large voids visualized by our microCT data. Further, there is no direct evidence of blood vessels inside these cavities from microscopy or SEM images, suggesting that secondary remodelling may not be playing a role. Thus, the first possibility is more likely. However, it should be noted that osteocytes inside already formed cortical bone have been proposed to be capable of resorbing formed bone (osteocytic osteolysis) by leaching and proteolytic process of osteocytes [6], [30], [31], [32]. While this view is contested [33] it is possible that enhanced removal of endocortical bone tissue by osteocytic osteolysis activated in GIOP [6]may also be a causative factor behind the large voids and cavities found, and at present we cannot conclusively exclude either possibility. The microstructure of the tissue toward the endosteal surface exhibit regions of low overall mineralization (Fig. 2B), which bear some resemblance to the lowered mineralized haloes observed in GIOP bone in [6], and also show some highly mineralized thin lines at their peripheries. The low mineralized zones also have a more heterogeneous distribution, as characterized by the larger FWHM in BMDD results (Fig. 2C). The overall reduction in mineral content and the increased heterogeneity in Crh− 120/+ (Fig. 1) may be linked to the adverse effect of glucocorticoid treatment on cellular activities.
Synchrotron X-ray microtomography data demonstrated that cavities are interconnected to each other along the longitudinal direction of the tibiae in Crh− 120/+ mice. Furthermore this 3D representation (Fig. 3 qualitatively) and morphometric evaluation (Fig. 4) showed that the Crh− 120/+ bones has reduced proportion of normal vascular network and less density of osteocyte lacunae compared to WT cortical bone. However, a much larger fraction of intracortical cavities are found, unique to Crh− 120/+ mice, which may be the late-stage result of enhanced osteocytic osteolysis inside the cortical shell [6], [24], [31], [32]. These findings are less apparent when investigating 2D-only images such as BSE imaging. Quantitative analysis of 3D morphological analysis such as canals density and lacuna density was performed in this study. Despite the limitation of small (3) number of samples capable of being measured in the limited synchrotron time, qualitatively and quantitatively significant differences in microstructure was observed between Crh− 120/+ and WT mice.
In terms of bone matrix mechanics, we observed significantly reduced (~ 50%) elastic modulus (Fig. 5A) and strength (Fig. 5B) in the femora of GIOP-exhibiting Crh− 120/+ mice at the macroscopic scale, which remain significant after correcting for elevated microstructural porosity in Crh− 120/+ (WT 2% and Crh− 120/+ 30%; Fig. S2). However, the origin of the material-level changes causing this mechanical deterioration may lie at either or both the micro (lamellar) and the ultrastructural length scale in the structural hierarchy. We find evidence that reduced stiffness at the fibrillar level plays an important role in this mechanical deterioration: the effective fibril moduli (σ/εF) in Crh− 120/+ mice are significantly (p < 0.05) less stiff (~ 75%) than controls (Fig. 6A and B). We speculate that the alterations could be due to the reduced stiffness in extrafibrillar environment in Crh− 120/+ tissue. In the linearly elastic region of deformation (Fig. 5A), the externally applied tensile strain can to be divided into a tensile stretching of the mineralized collagen fibril together with deformation at larger length scales, which may include shear in the extrafibrillar matrix between fibrils [34] or between lamellae. Our in situ SAXD results show (Fig. 6C) that because the fibril modulus is lower, the maximum deformation in the mineralized fibrils in Crh− 120/+ is significantly higher (up to ~ 0.63%) relative to WT (up to ~ 0.3%).
The fibril-strain/tissue-strain ratio in the WT mineralized collagen fibrils is ~½ (Fig. 6D), consistent with previous in situ SAXD on bovine fibrolamellar bone, but in contrast, the fibril-to-tissue strain ratio for Crh− 120/+ bone is ~ 1, within experimental error. While an increase in fibril-strain/tissue-strain ratio in well-oriented bovine fibrolamellar bone was earlier explained by us [15] as due to increased mineralization in the extrafibrillar compartment, this mechanism clearly cannot hold for the osteoporotic Crh− 120/+ mice, because they exhibit significant reduction in degree of mineralization (Fig. 2B). As the fibril orientation distribution (reflecting lamellar level architecture) is significantly more random in Crh− 120/+ than in WT (Fig. 6E), we conclude that microscale inhomogeneity in lamellar level fibril orientation in Crh− 120/+ may be playing a significant role in the altered fibril-strain/tissue-strain ratio as well as in the altered macroscale mechanics. The alterations of macroscopic mechanics with fibril orientation is consistent with a recent study showing that microfibril orientation dominates the local elastic properties of lamellar bone [35], The alteration in fibril-strain/tissue strain ratio is quite consistent with the highly porous, heterogeneous mineralized matrix observed in Fig. 1B. In such a system, the local tissue strain (distinct from the global tissue strain εT) in the more randomly oriented fibrils in Crh− 120/+ mice will be different when compared with WT mice.
Our results show (Fig. 6F) that the mineralized fibrils in both groups undergo a reduction in degree of fibrillar orientation on loading, which corresponds physically to a stress-induced alignment of the fibrils toward the loading axis. However, the rate of the fibrillar reorientation is different between Crh− 120/+ and WT with a significantly lower rate of reorientation in Crh− 120/+ mice. Prior to discussing these differences, however, the magnitudes of the changes in the width of the fibril angular distribution (Fig. 6F) deserve comment. For tissue strains of ~ 1–2% (and equivalent fibril strains of ~ 0.5–1%) we observe much larger percentage changes in the width, of the order of 10–20%. At first glance this finding of relatively large reduction in the width is a very surprising result, as it is expected that the percentage change of the angular distribution will be comparable to the percentage change of the fibrillar elongation, and not much larger. It is important to note that the large angular change is not related to the disease-phenotype — both WT and Crh− 120/+ specimens have comparable order of magnitude effects, and the Crh− 120/+ reorientation is actually lower (Fig. 6F). In order to exclude artefacts from our data analysis, we took special care to fit the angular intensity profile to a Gaussian without a baseline as we found (data not shown) that the introduction of an artificial baseline significantly affected (reduced) the width of the peak of the remaining Gaussian, and as a result the percentage reductions were even larger. Further, we kept the meridional width of the 3rd order reflection (used for radial averaging) large enough such that all the intensity in the peak was averaged, not just the intensity along the meridional peak position. Lastly (data not shown), to exclude the possibility that this large change was a characteristic of our mouse bone cortical specimen preparation protocol, a comparable analysis of the percentage change in fibril width for standard tissue types like the bovine fibrolamellar bone and antler cortical tested by us previously [20] show similarly large reductions of the order of ~ 10% for strains < 1%. We can therefore say with confidence that this effect is a real one which is characteristic of cortical bone of various types in our samples.
In order to explain this large reduction, we need to consider the local loading environment of the fibril. If we assume (incorrectly, as it will turn out) that the fibrils and surrounding interfibrillar matrix are in an strain-controlled deformation mode, then it can be readily seen that the percentage change of angular position of the fibrils is of the same order as the fibril strain itself (Fig. 7A inset i), which is not what is observed. However, if we consider the fibrils to be relatively rigid fibers in a partially ductile interfibrillar matrix which transmits shear [20], it can be seen (Fig. 7A inset ii) that while the fibril strain can be small (due to the high axial stiffness of the rigid fiber) the reorientation of the fiber due to the resolved force perpendicular to the fiber can be significant (due to the lower stiffness of the extrafibrillar matrix). It is therefore clear that large percentage reduction in angular width of the fibril distribution, relative to the fibril strain, can be definitely possible in this case, and that the effect will be larger as the stiffness ratio between interfibrillar matrix and fibers increases. With this in mind, it is possible to consider the reduced rate of reorientation in GIOP as a possible alteration of the stiffness ratio between the mineralized fibrils and the extrafibrillar matrix, specifically to a stiffer extrafibrillar matrix and less stiff fibrils. In the absence of a detailed TEM level study of the type in [28], our discussion is speculative, but the reduced reorientation may indicate that the fibrils in GIOP are less completely mineralized (at the intrafibrillar level) than in WT, or that an excessive mineral deposition occurs outside of the fibrillar compartment.
We can also link the altered microstructure in Crh− 120/+ mice – specifically the demineralized structures (halos) around osteocytes (Fig. 1B) [24], the reduced frequency of osteocytes (Fig. 1, Fig. 3), and their qualitative shape – to the changed fibrillar mechanics and the altered loading environment in the bone tissue of Crh− 120/+ mice. Previous work has found that the geometrical properties and shape of osteocytes lacunae depend on age [36], anatomical site [37] and collagen fibre arrangement [38], with more elongated osteocytes in regions of greater collagen fibre alignment and rounder osteocytes in tissues with more random fibre orientation like woven bone. Here, our SAXD results showed that fibrillar orientation of Crh− 120/+ mice is lower (more random) than in WT mice (Fig. 6E), and also that the fibril modulus is lower (Fig. 6B). It is therefore likely that this alteration in the collagen fibril orientation and mechanics is linked to the change in osteocyte morphology to a less elongated structure [7], [24]. The alterations in intracortical porosity will most likely also play a significant role in reduction of mechanical competence, since extrinsic toughening mechanisms like crack bridging and crack deflection depend sensitively on the lamellar structure, orientation and mineralization [39], [40].These microstructural alterations may arise by three main mechanisms (i) crack path deflection at the interface between the lower mineralized halos and the surrounding tissue, or crack initiation at the cement lines around the halos, both of which will change the fracture toughness and (ii) a disrupted mechanosensory osteocytic network [27] and to the apoptosis of osteocytes [2], [41]. Fig. 7 shows some key elements in the alteration of the mineralized matrix in Crh− 120/+ mice, encapsulating the lower mineralization, more extensible and greater randomness of the fibrillar network.
5. Conclusion
In this study we demonstrated that in a mouse model for glucocorticoid-induced osteoporosis, both the fibrillar deformation mechanisms at the nanoscale and the microscale mineralization distribution are significantly altered compared to healthy bone. At the nanometre length scale, we found altered fibrillar deformation (increased extensibility and lower fibril modulus) in Crh− 120/+ mice bone, as well as less oriented fibrils. At the microscale in Crh− 120/+ mice, a lower mineral content, increased heterogeneity in mineralization near osteocytes and significant alterations in the three-dimensional mineralized matrix is observed. In contrast, WT bone is more uniformly mineralized as shown by the qBSE results. We propose that the altered deformation mechanisms at the nanoscale – increased flexibility, lower fibril modulus, altered fibrillar reorientation – in conjunction with altered microstructural toughening mechanisms due to heterogeneous mineralization are critical factors leading to the increased macroscopic fragility in GIOP.
The following are the supplementary data related to this article.
Funding sources
Medical Research Council UK; Diamond Light Source Ltd., Diamond House, Oxfordshire, UK; School of Engineering and Material Sciences, Queen Mary University of London, London, E1 4NS, UK; Engineering and Physical Research Council (EPSRC) UK, Swindon, UK.
Disclosure
The authors state that they have no conflicts of interest.
Conflict of interest
All authors have no conflict of interest.
Acknowledgements
The authors thank the Medical Research Council for funding (G0600702). AK acknowledges Diamond Light Source and Queen Mary University of London for funding ((MATL1D8R and CDTA SEM7100b). XL thanks the China Scholarship Council and Diamond Light Source for funding (SEML1B4R).
Contributor Information
A. Karunaratne, Email: a.karunaratne@imperial.ac.uk.
L. Xi, Email: l.xi@qmul.ac.uk.
L. Bentley, Email: l.bentley@har.mrc.ac.uk.
D. Sykes, Email: d.sykes@nhm.ac.uk.
A. Boyde, Email: a.boyde@qmul.ac.uk.
C.T. Esapa, Email: c.esapa@har.mrc.ac.uk.
N.J. Terrill, Email: nick.terrill@diamond.ac.uk.
S.D.M. Brown, Email: s.brown@har.mrc.ac.uk.
R.D. Cox, Email: r.cox@har.mrc.ac.uk.
R.V. Thakker, Email: rajesh.thakker@ndm.ox.ac.uk.
H.S. Gupta, Email: h.gupta@qmul.ac.uk.
References
- 1.Van Staa T.P., Laan R.F., Barton I.P., Cohen S., Reid D.M., Cooper C. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum. 2003;48:3224–3229. doi: 10.1002/art.11283. [DOI] [PubMed] [Google Scholar]
- 2.Weinstein R.S. Glucocorticoid-induced bone disease. N. Engl. J. Med. 2011;365:62–70. doi: 10.1056/NEJMcp1012926. [DOI] [PubMed] [Google Scholar]
- 3.Tóth M., Grossman A. Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome. Clin. Endocrinol. 2013;79:1–11. doi: 10.1111/cen.12189. [DOI] [PubMed] [Google Scholar]
- 4.Mazziotti G., Angeli A., Bilezikian J.P., Canalis E., Giustina A. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol. Metab. 2006;17:144–149. doi: 10.1016/j.tem.2006.03.009. [DOI] [PubMed] [Google Scholar]
- 5.Hayashi K., Yamamoto M., Murakawa Y., Yamauchi M., Kaji H., Yamaguchi T., Sugimoto T. Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density. Osteoporos. Int. 2009;20:1889–1894. doi: 10.1007/s00198-009-0901-6. [DOI] [PubMed] [Google Scholar]
- 6.Lane N.E., Yao W., Balooch M., Nalla R.K., Balooch G., Habelitz S., Kinney J.H., Bonewald L.F. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J. Bone Miner. Res. 2006;21:466–476. doi: 10.1359/JBMR.051103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Balooch G., Yao W., Ager J.W., Balooch M., Nalla R.K., Porter A.E., Ritchie R.O., Lane N.E. The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids. Arthritis Rheum. 2007;56:3726–3737. doi: 10.1002/art.22976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Dalle Carbonare L., Bertoldo F., Valenti M.T., Zenari S., Zanatta M., Sella S., Giannini S., Cascio V.L. Histomorphometric analysis of glucocorticoid-induced osteoporosis. Micron. 2005;36:645–652. doi: 10.1016/j.micron.2005.07.009. [DOI] [PubMed] [Google Scholar]
- 9.Poundarik A.A., Diab T., Sroga G.E., Ural A., Boskey A.L., Gundberg C.M., Vashishth D. Dilatational band formation in bone. Proc. Natl. Acad. Sci. 2012;109:19178–19183. doi: 10.1073/pnas.1201513109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Zimmermann E.A., Schaible E., Bale H., Barth H.D., Tang S.Y., Reichert P., Busse B., Alliston T., Ager J.W., 3rd, Ritchie R.O. Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales. Proc. Natl. Acad. Sci. U. S. A. 2011 doi: 10.1073/pnas.1107966108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Fratzl P., Weinkamer R. Nature's hierarchical materials. Prog. Mater. Sci. 2007;52:1263–1334. [Google Scholar]
- 12.Meyers M.A., Chen P.Y., Lin A.Y.M., Seki Y. Biological materials: structure and mechanical properties. Prog. Mater. Sci. 2008;53:1–206. doi: 10.1016/j.jmbbm.2008.02.003. [DOI] [PubMed] [Google Scholar]
- 13.Bentley L., Esapa C.T., Nesbit M.A., Head R.A., Evans H., Lath D., Scudamore C.L., Hough T.A., Podrini C., Hannan F.M., Fraser W.D., Croucher P.I., Brown M.A., Brown S.D., Cox R.D., Thakker R.V. An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess. Endocrinology. 2014;155:908–922. doi: 10.1210/en.2013-1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Gupta H.S., Wagermaier W., Zickler G.A., Aroush D.R.B., Funari S.S., Roschger P., Wagner H.D., Fratzl P. Nanoscale deformation mechanisms in bone. Nano Lett. 2005;5(10):2108–2111. doi: 10.1021/nl051584b. [DOI] [PubMed] [Google Scholar]
- 15.Gupta H.S., Seto J., Wagermaier W., Zaslansky P., Boesecke P., Fratzl P. Cooperative deformation of mineral and collagen in bone at the nanoscale. Proc. Natl. Acad. Sci. U. S. A. 2006;103:17741–17746. doi: 10.1073/pnas.0604237103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Karunaratne A., Boyde A., Esapa C.T., Hiller J., Terrill N.J., Brown S.D.M., Cox R.D., Thakker R.V., Gupta H.S. Symmetrically reduced stiffness and increased extensibility in compression and tension at the mineralized fibrillar level in rachitic bone. Bone. 2013;52:689–698. doi: 10.1016/j.bone.2012.10.029. [DOI] [PubMed] [Google Scholar]
- 17.Karunaratne A., Esapa C.R., Hiller J., Boyde A., Head R., Bassett J.H.D., Terrill N.J., Williams G.R., Brown M.A., Croucher P.I., Brown S.D.M., Cox R.D., Barber A.H., Thakker R.V., Gupta H.S. Significant deterioration in nanomechanical quality occurs through incomplete extrafibrillar mineralization in rachitic bone: evidence from in-situ synchrotron X-ray scattering and backscattered electron imaging. J. Bone Miner. Res. 2012;27:876–890. doi: 10.1002/jbmr.1495. [DOI] [PubMed] [Google Scholar]
- 18.Roschger P., Paschalis E.P., Fratzl P., Klaushofer K. Bone mineralization density distribution in health and disease. Bone. 2008;42:456–466. doi: 10.1016/j.bone.2007.10.021. [DOI] [PubMed] [Google Scholar]
- 19.Barth H.D., Launey M.E., MacDowell A.A., Ager J.W., Ritchie R.O. On the effect of X-ray irradiation on the deformation and fracture behavior of human cortical bone. Bone. 2010;46:1475–1485. doi: 10.1016/j.bone.2010.02.025. [DOI] [PubMed] [Google Scholar]
- 20.Gupta H.S., Krauss S., Kerschnitzki M., Karunaratne A., Dunlop J.W., Barber A.H., Boesecke P., Funari S.S., Fratzl P. Intrafibrillar plasticity through mineral/collagen sliding is the dominant mechanism for the extreme toughness of antler bone. J. Mech. Behav. Biomed. Mater. 2013;28:366–382. doi: 10.1016/j.jmbbm.2013.03.020. [DOI] [PubMed] [Google Scholar]
- 21.Bouvard B., Audran M., Legrand E., Chappard D. Ultrastructural characteristics of glucocorticoid-induced osteoporosis. Osteoporos. Int. 2009;20:1089–1092. doi: 10.1007/s00198-009-0864-7. [DOI] [PubMed] [Google Scholar]
- 22.Chappard D., Legrand E., Basle M.F., Fromont P., Racineux J.L., Rebel A., Audran M. Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J. Bone Miner. Res. 1996;11:676–685. doi: 10.1002/jbmr.5650110516. [DOI] [PubMed] [Google Scholar]
- 23.Saag K.G., Emkey R., Schnitzer T.J., Brown J.P., Hawkins F., Goemaere S., Thamsborg G., Liberman U.A., Delmas P.D., Malice M.P., Czachur M., Daifotis A.G., Interven G.-I.O. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N. Engl. J. Med. 1998;339:292–299. doi: 10.1056/NEJM199807303390502. [DOI] [PubMed] [Google Scholar]
- 24.Lane N.E., Yao W. Glucocorticoid-induced bone fragility. Ann. N. Y. Acad. Sci. 2010;1192:81–83. doi: 10.1111/j.1749-6632.2009.05228.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Yao W., Cheng Z., Pham A., Busse C., Zimmermann E.A., Ritchie R.O., Lane N.E. Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. Arthritis Rheum. 2008;58:3485–3497. doi: 10.1002/art.23954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Canalis E., Mazziotti G., Giustina A., Bilezikian J. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos. Int. 2007;18:1319–1328. doi: 10.1007/s00198-007-0394-0. [DOI] [PubMed] [Google Scholar]
- 27.Bonewald L.F., Johnson M.L. Osteocytes, mechanosensing and Wnt signaling. Bone. 2008;42:606–615. doi: 10.1016/j.bone.2007.12.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Alexander B., Daulton T.L., Genin G.M., Lipner J., Pasteris J.D., Wopenka B., Thomopoulos S. The nanometre-scale physiology of bone: steric modelling and scanning transmission electron microscopy of collagen-mineral structure. J. R. Soc. Interface. 2012;9:1774–1786. doi: 10.1098/rsif.2011.0880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Weinstein R.S., Chen J.R., Powers C.C., Stewart S.A., Landes R.D., Bellido T., Jilka R.L., Parfitt A.M., Manolagas S.C. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J. Clin. Investig. 2002;109:1041–1048. doi: 10.1172/JCI14538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Heuck F. Comparative investigations of the function of osteocytes in bone resorption. Calcif. Tissue Res. 1970;Suppl.:148–149. doi: 10.1007/BF02152400. [DOI] [PubMed] [Google Scholar]
- 31.Yao W., Dai W., Jiang J.X., Lane N.E. Glucocorticoids and osteocyte autophagy. Bone. 2013;54:279–284. doi: 10.1016/j.bone.2013.01.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Bonewald L.F. The amazing osteocyte. J. Bone Miner. Res. 2011;26:229–238. doi: 10.1002/jbmr.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Boyde A. Evidence against osteocytic osteolysis. Metab. Bone Dis. Relat. Res. 1980;2S:17. [Google Scholar]
- 34.Gupta H., Wagermaier W., Zickler G., Hartmann J., Funari S., Roschger P., Wagner H., Fratzl P. Fibrillar level fracture in bone beyond the yield point. Int. J. Fract. 2006;139:425–436. [Google Scholar]
- 35.Granke M., Gourrier A., Rupin F., Raum K., Peyrin F., Burghammer M., Saïed A., Laugier P. Microfibril orientation dominates the microelastic properties of human bone tissue at the lamellar length scale. PLoS One. 2013;8 doi: 10.1371/journal.pone.0058043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Hirose S., Li M., Kojima T., de Freitas P.H.L., Ubaidus S., Oda K., Saito C., Amizuka N. A histological assessment on the distribution of the osteocytic lacunar canalicular system using silver staining. J. Bone Miner. Metab. 2007;25:374–382. doi: 10.1007/s00774-007-0764-x. [DOI] [PubMed] [Google Scholar]
- 37.Vatsa A., Breuls R.G., Semeins C.M., Salmon P.L., Smit T.H., Klein-Nulend J. Osteocytemorphology in fibula and calvaria — Is there a role for mechanosensing? Bone. 2008;43:452–458. doi: 10.1016/j.bone.2008.01.030. [DOI] [PubMed] [Google Scholar]
- 38.Remaggi F., Cane V., Palumbo C., Ferretti M. Histomorphometric study on the osteocyte lacuno-canalicular network in animals of different species. I. Woven-fibered and parallel-fibered bones. Ital. J. Anat. Embryol. 1998;103:145–155. [PubMed] [Google Scholar]
- 39.Reilly G.C. Observations of microdamage around osteocyte lacunae in bone. J. Biomech. 2000;33:1131–1134. doi: 10.1016/s0021-9290(00)00090-7. [DOI] [PubMed] [Google Scholar]
- 40.Reilly G.C., Currey J.D. The effects of damage and microcracking on the impact strength of bone. J. Biomech. 2000;33:337–343. doi: 10.1016/s0021-9290(99)00167-0. [DOI] [PubMed] [Google Scholar]
- 41.Schneider P., Meier M., Wepf R., Muller R. Towards quantitative 3D imaging of the osteocyte lacuno-canalicular network. Bone. 2010;47:848–858. doi: 10.1016/j.bone.2010.07.026. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.